<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?>
<feed xmlns="http://www.w3.org/2005/Atom">
  <id>http://finance.google.com/group/google.finance.13805350</id>
  <title type="text">Nanobac Pharmaceuticals Google Group</title>
  <subtitle type="text">
  Google Finance Discussion for Nanobac Pharmaceuticals (OTC:NNBP)
  </subtitle>
  <link href="/group/google.finance.13805350/feed/atom_v1_0_topics.xml" rel="self" title="Nanobac Pharmaceuticals feed"/>
  <updated>-0-0T::Z</updated>
  <generator uri="http://finance.google.com" version="1.99">Google Groups</generator>
  <entry>
  <author>
  <name>donpat@donpatent.com</name>
  <email>donpat...@gmail.com</email>
  </author>
  <updated>2008-02-22T14:31:51Z</updated>
  <id>http://finance.google.com/group/google.finance.13805350/browse_thread/thread/1c62555293594852</id>
  <link href="http://finance.google.com/group/google.finance.13805350/browse_thread/thread/1c62555293594852" />
  <title type="html">Human-derived nanoparticles and vascular response to injury in rabbit carotid arteries: Proof of principle</title>
  <summary type="html" xml:space="preserve">
  Friday, February 22, 2008 &lt;br&gt; International Journal of Nanomedicine &lt;br&gt; &lt;p&gt;Human-derived nanoparticles and vascular response to injury in rabbit &lt;br&gt; carotid arteries: Proof of principle &lt;br&gt; &lt;p&gt;Maria A K Schwartz1, John C Lieske2, Vivek Kumar2, Gerard Farell- &lt;br&gt; Baril2, Virginia M Miller1,3 &lt;br&gt; &lt;p&gt;1Departments of Physiology and Biomedical Engineering, Internal
  </summary>
  </entry>
  <entry>
  <author>
  <name>donpat@donpatent.com</name>
  <email>donpat...@gmail.com</email>
  </author>
  <updated>2008-02-19T17:09:38Z</updated>
  <id>http://finance.google.com/group/google.finance.13805350/browse_thread/thread/91bbead80eb6cb77</id>
  <link href="http://finance.google.com/group/google.finance.13805350/browse_thread/thread/91bbead80eb6cb77" />
  <title type="html">Association of Nanoparticle and Kidney Stone Formation</title>
  <summary type="html" xml:space="preserve">
  Nanobac Announces Publication of Association of Nanoparticle and &lt;br&gt; Kidney Stone Formation &lt;br&gt; &lt;p&gt;Results May Change Approach to Medical Management of Kidney Stones &lt;br&gt; &lt;p&gt;Last update: 11:28 a.m. EST Feb. 19, 2008 &lt;br&gt; &lt;p&gt;TAMPA, FL, Feb 19, 2008 (MARKET WIRE via COMTEX) -- Nanobac &lt;br&gt; Pharmaceuticals Inc. (&amp;quot;Nanobac&amp;quot; or &amp;quot;the Company&amp;quot;) announces
  </summary>
  </entry>
  <entry>
  <author>
  <name>donpat@donpatent.com</name>
  <email>donpat...@gmail.com</email>
  </author>
  <updated>2008-02-07T14:39:13Z</updated>
  <id>http://finance.google.com/group/google.finance.13805350/browse_thread/thread/c63d980a3ad8dc7d</id>
  <link href="http://finance.google.com/group/google.finance.13805350/browse_thread/thread/c63d980a3ad8dc7d" />
  <title type="html">Legal Team to Enforce Patent Rights</title>
  <summary type="html" xml:space="preserve">
  Nanobac Pharmaceuticals Inc. Engages Legal Team to Enforce Patent &lt;br&gt; Rights &lt;br&gt; &lt;p&gt;Last update: 9:15 a.m. EST Feb. 7, 2008 &lt;br&gt; &lt;p&gt;TAMPA, Fla., Feb 07, 2008 (BUSINESS WIRE) -- Nanobac Pharmaceuticals &lt;br&gt; Inc. (&amp;quot;Nanobac&amp;quot; or &amp;quot;the Company&amp;quot;) is pleased to announce that it has &lt;br&gt; engaged Guy Ricciardulli for services related to claims for damages,
  </summary>
  </entry>
  <entry>
  <author>
  <name>donpat@donpatent.com</name>
  <email>donpat...@gmail.com</email>
  </author>
  <updated>2008-01-22T16:07:04Z</updated>
  <id>http://finance.google.com/group/google.finance.13805350/browse_thread/thread/9bdec471dc309b51</id>
  <link href="http://finance.google.com/group/google.finance.13805350/browse_thread/thread/9bdec471dc309b51" />
  <title type="html">Nanobac Announces European Heart Journal Publication of Association Between Calcifying Nanoparticles and Aortic Stenosis</title>
  <summary type="html" xml:space="preserve">
  Nanobac Announces European Heart Journal Publication of Association &lt;br&gt; Between Calcifying Nanoparticles and Aortic Stenosis &lt;br&gt; &lt;p&gt;Last update: 10:59 a.m. EST Jan. 22, 2008 &lt;br&gt; &lt;p&gt;TAMPA, Fla., Jan 22, 2008 (BUSINESS WIRE) -- Nanobac Pharmaceuticals &lt;br&gt; Inc. (&amp;quot;Nanobac&amp;quot; or &amp;quot;the Company&amp;quot;) announces the multicenter
  </summary>
  </entry>
  <entry>
  <author>
  <name>donpat@donpatent.com</name>
  <email>donpat...@gmail.com</email>
  </author>
  <updated>2008-01-21T16:39:36Z</updated>
  <id>http://finance.google.com/group/google.finance.13805350/browse_thread/thread/1a86baec2ff1bae7</id>
  <link href="http://finance.google.com/group/google.finance.13805350/browse_thread/thread/1a86baec2ff1bae7" />
  <title type="html">Ultrafine Air Pollution May Cause Heart Disease</title>
  <summary type="html" xml:space="preserve">
  Ultrafine Air Pollution May Cause Heart Disease, Researchers Say &lt;br&gt; &lt;p&gt;January 21, 2008 5:36 a.m. EST &lt;br&gt; &lt;p&gt;Paul Icamina - AHN News Writer &lt;br&gt; &lt;p&gt;Los Angeles, CA (AHN) - Air pollution can be bad for the heart. &lt;br&gt; Similar to the hazards of second hand smoke, nanoparticles in air &lt;br&gt; pollution may promote hardening of the arteries and cause heart
  </summary>
  </entry>
  <entry>
  <author>
  <name>donpat@donpatent.com</name>
  <email>donpat...@gmail.com</email>
  </author>
  <updated>2008-01-15T22:41:19Z</updated>
  <id>http://finance.google.com/group/google.finance.13805350/browse_thread/thread/689c5e81b5f72b2d</id>
  <link href="http://finance.google.com/group/google.finance.13805350/browse_thread/thread/689c5e81b5f72b2d" />
  <title type="html">Nanobac Announces Baylor College of Medicine Initial Results for Nanoparticle and Gall Stone Formation Study</title>
  <summary type="html" xml:space="preserve">
  Nanobac Announces Baylor College of Medicine Initial Results for &lt;br&gt; Nanoparticle and Gall Stone Formation Study &lt;br&gt; Jan 15 2008, 9:23 AM EST &lt;br&gt; &lt;p&gt;News source: Business Wire &lt;br&gt; &lt;p&gt;Nanobac Pharmaceuticals Inc. (OTCBB:NNBP) (&amp;quot;Nanobac&amp;quot; or &amp;quot;the Company&amp;quot;) &lt;br&gt; announces that scientists at the Baylor College of Medicine, working
  </summary>
  </entry>
  <entry>
  <author>
  <name>donpat@donpatent.com</name>
  <email>donpat...@gmail.com</email>
  </author>
  <updated>2007-10-29T18:00:27Z</updated>
  <id>http://finance.google.com/group/google.finance.13805350/browse_thread/thread/ca882c494d34eb22</id>
  <link href="http://finance.google.com/group/google.finance.13805350/browse_thread/thread/ca882c494d34eb22" />
  <title type="html">Nanobac Pharmaceuticals Inc. to Present at the Fall Life Sciences Conference in New York</title>
  <summary type="html" xml:space="preserve">
  Nanobac Pharmaceuticals Inc. to Present at the Fall Life Sciences &lt;br&gt; Conference in New York Premier Event to Be Held November 1st &lt;br&gt; NNBP today announced that it has been invited to present at Friedland &lt;br&gt; Investment Events&#39; Life Sciences Conference in New York. The &lt;br&gt; Conference will be held November 1st at the DoubleTree Hotel Times
  </summary>
  </entry>
  <entry>
  <author>
  <name>donpat@donpatent.com</name>
  <email>donpat...@gmail.com</email>
  </author>
  <updated>2007-10-10T22:07:21Z</updated>
  <id>http://finance.google.com/group/google.finance.13805350/browse_thread/thread/82e9e41e9fcff3b0</id>
  <link href="http://finance.google.com/group/google.finance.13805350/browse_thread/thread/82e9e41e9fcff3b0" />
  <title type="html">Microscopic Observation of Self-Propagation of Calcifying Nanoparticles (Nanobacteria)</title>
  <summary type="html" xml:space="preserve">
  Title: Microscopic Observation of Self-Propagation of Calcifying &lt;br&gt; Nanoparticles (Nanobacteria) &lt;br&gt; Author(s): Mathew, Grace; McKay, David S.; Ciftcioglu, Neva &lt;br&gt; Abstract: Biologists typically define living organisms as carbon and &lt;br&gt; water-based cellular forms with self-replication&amp;quot; as the fundamental &lt;br&gt; trait of the life process. However, this standard dictionary
  </summary>
  </entry>
  <entry>
  <author>
  <name>donpat@donpatent.com</name>
  <email>donpat...@gmail.com</email>
  </author>
  <updated>2007-10-03T15:26:21Z</updated>
  <id>http://finance.google.com/group/google.finance.13805350/browse_thread/thread/6253b2bb5cf033ec</id>
  <link href="http://finance.google.com/group/google.finance.13805350/browse_thread/thread/6253b2bb5cf033ec" />
  <title type="html">Calgenex tackles calcification</title>
  <summary type="html" xml:space="preserve">
  Calgenex tackles calcification &lt;br&gt; By Clarisse Douaud &lt;br&gt; 9/13/2006 - New manufacturer and marketer Calgenex Corporation is &lt;br&gt; taking the condition-specific approach to supplementation to a very &lt;br&gt; specific level - tackling soft tissue calcification with a range of &lt;br&gt; products. &lt;br&gt; In an effort to set themselves apart from the crowd, more and more
  </summary>
  </entry>
  <entry>
  <author>
  <name>donpat@donpatent.com</name>
  <email>donpat...@gmail.com</email>
  </author>
  <updated>2007-09-22T20:28:57Z</updated>
  <id>http://finance.google.com/group/google.finance.13805350/browse_thread/thread/cf1a67d972faabe7</id>
  <link href="http://finance.google.com/group/google.finance.13805350/browse_thread/thread/cf1a67d972faabe7" />
  <title type="html">Continuation of Space Act Agreement with NASA</title>
  <summary type="html" xml:space="preserve">
  Nanobac Pharmaceuticals Announces Continuation of Space Act Agreement &lt;br&gt; with NASA: NASA to Study Characterization of the Physical and Chemical &lt;br&gt; Properties of Calcifying Nano Particles and Their Role in Calcifying &lt;br&gt; Diseases &lt;br&gt; Last Update: 9:15 AM ET Sep 18, 2007 &lt;br&gt; TAMPA, Fla., Sep 18, 2007 (BUSINESS WIRE) -- Nanobac Pharmaceuticals
  </summary>
  </entry>
  <entry>
  <author>
  <name>donpat@donpatent.com</name>
  <email>donpat...@gmail.com</email>
  </author>
  <updated>2007-09-12T13:23:26Z</updated>
  <id>http://finance.google.com/group/google.finance.13805350/browse_thread/thread/6dc5c4945dae21f0</id>
  <link href="http://finance.google.com/group/google.finance.13805350/browse_thread/thread/6dc5c4945dae21f0" />
  <title type="html">Agreement with American Health Associates</title>
  <summary type="html" xml:space="preserve">
  Agreement with American Health Associates &lt;br&gt; Nanobac Pharmaceuticals Inc. Signs Agreement with American Health &lt;br&gt; Associates Clinical Laboratories to Provide Calcifying Nanoparticle &lt;br&gt; Tests in the United States &lt;br&gt; &amp;quot;Test Available 4th Quarter 2007&amp;quot; &lt;br&gt; Last Update: 9:15 AM ET Sep 12, 2007 &lt;br&gt; TAMPA, Fla., Sep 12, 2007 (BUSINESS WIRE) -- Nanobac Pharmaceuticals
  </summary>
  </entry>
  <entry>
  <author>
  <name>donpat@donpatent.com</name>
  <email>donpat...@gmail.com</email>
  </author>
  <updated>2007-09-06T16:55:43Z</updated>
  <id>http://finance.google.com/group/google.finance.13805350/browse_thread/thread/0ae8d897528b1a27</id>
  <link href="http://finance.google.com/group/google.finance.13805350/browse_thread/thread/0ae8d897528b1a27" />
  <title type="html">Superbugs, shapes and nanotechnology</title>
  <summary type="html" xml:space="preserve">
  Superbugs, shapes and nanotechnology &lt;br&gt; A common hospital superbug called Clostridium has a protective coat of &lt;br&gt; armour that can self assemble when put into a test tube on its own, &lt;br&gt; which may have important commercial uses in nanotechnology, according &lt;br&gt; to scientists speaking today at the Society for General Microbiology&#39;s
  </summary>
  </entry>
  <entry>
  <author>
  <name>donpat@donpatent.com</name>
  <email>donpat...@gmail.com</email>
  </author>
  <updated>2007-08-23T16:22:47Z</updated>
  <id>http://finance.google.com/group/google.finance.13805350/browse_thread/thread/091d7cc9d7317425</id>
  <link href="http://finance.google.com/group/google.finance.13805350/browse_thread/thread/091d7cc9d7317425" />
  <title type="html">Nanobac Pharmaceuticals Intends to Join High Risk Plaque Initiative</title>
  <summary type="html" xml:space="preserve">
  Nanobac Pharmaceuticals Intends to Join High Risk Plaque Initiative &lt;br&gt; Study May Provide Conclusive Data on the Role of Calcified &lt;br&gt; NanoParticles in Heart Disease &lt;br&gt; Last Update: 10:08 AM ET Aug 23, 2007 &lt;br&gt; TAMPA, Fla., Aug 23, 2007 (BUSINESS WIRE) -- Nanobac Pharmaceuticals &lt;br&gt; Inc. (NNBP: &lt;br&gt; nanobac pharmaceuticals inc com NNBP 0.06, +0.00, +5.0%) , &amp;quot;Nanobac&amp;quot;
  </summary>
  </entry>
  <entry>
  <author>
  <name>donpat@donpatent.com</name>
  <email>donpat...@gmail.com</email>
  </author>
  <updated>2007-08-21T17:44:06Z</updated>
  <id>http://finance.google.com/group/google.finance.13805350/browse_thread/thread/67a4322b919a60d1</id>
  <link href="http://finance.google.com/group/google.finance.13805350/browse_thread/thread/67a4322b919a60d1" />
  <title type="html">Nanobac Announces Results for Nanoparticle and Kidney Stone Formation Study</title>
  <summary type="html" xml:space="preserve">
  Nanobac Announces Results for Nanoparticle and Kidney Stone Formation &lt;br&gt; Study &lt;br&gt; Tuesday August 21, 10:06 am ET &lt;br&gt; Results May Change Approach to Medical Management of Kidney Stones &lt;br&gt; TAMPA, Fla.--(BUSINESS WIRE)--Nanobac Pharmaceuticals Inc. (OTCBB:NNBP &lt;br&gt; - News; &amp;quot;Nanobac&amp;quot; or &amp;quot;the Company&amp;quot;) announces that scientists from the
  </summary>
  </entry>
  <entry>
  <author>
  <name>donpat@donpatent.com</name>
  <email>donpat...@gmail.com</email>
  </author>
  <updated>2007-08-16T15:07:36Z</updated>
  <id>http://finance.google.com/group/google.finance.13805350/browse_thread/thread/87f08b9fa74d0401</id>
  <link href="http://finance.google.com/group/google.finance.13805350/browse_thread/thread/87f08b9fa74d0401" />
  <title type="html">Space Flights Calcifying Nanoparticles (Nanobacteria) A Case Report</title>
  <summary type="html" xml:space="preserve">
  Title: An Additional Potential Factor for Kidney Stone Formation &lt;br&gt; during Space Flights Calcifying Nanoparticles (Nanobacteria) A Case &lt;br&gt; Report &lt;br&gt; Author(s): Jones, Jeffrey A.; Ciftcioglu, Neva; Schmid, Joseph; &lt;br&gt; Griffith, Donald &lt;br&gt; Abstract: Spaceflight-induced microgravity appears to be a risk &lt;br&gt; factor for the development of urinary calculi due to skeletal calcium
  </summary>
  </entry>
</feed>
